Guidelines for the use of cytotoxic drugs in non-malignant disease1
| Well established diagnosis |
|  Severe, potentially life threatening disease |
| Inadequate response to less toxic therapy |
| No known infection or neoplasm |
| No pregnancy or possibility thereof |
| Informed consent obtained |
| Availability of adequate facilities to monitor and treat complications |